Shares of Amarin (AMRN -2.2%) slip out of the gate this morning, possibly on cautious comments...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Shares of Amarin (AMRN -2.2%) slip out of the gate this morning, possibly on cautious comments out of Summer Street. The firm says Vascepa doesn't have data to support superiority compared to other fish oils such as Lovaza by Glaxo SmithKline (GSK -0.6%) which third party payers are likely to favor.